Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts
Open Access
- 1 February 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (2) , 355-357
- https://doi.org/10.1128/aac.21.2.355
Abstract
In vitro studies based on periodic viable count determinations indicated that the two antifungal drugs ketoconazole and 5-fluorocytosine generally were at least additive in their combined effect on various opportunistic yeast pathogens, including some resistant to 5-fluorocytosine.This publication has 9 references indexed in Scilit:
- Treatment of Coccidioidomycosis with Ketoconazole: Clinical and Laboratory Studies of 18 PatientsClinical Infectious Diseases, 1980
- Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band KetoconazoleClinical Infectious Diseases, 1980
- In vitro synergy and antagonism of antifungal agents against yeast-like fungiPublished by Oxford University Press (OUP) ,1979
- Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agentJournal of Medicinal Chemistry, 1979
- Ketoconazole — a new broad spectrum orally active antimycoticCellular and Molecular Life Sciences, 1979
- Severe Candidal InfectionsAnnals of Internal Medicine, 1978
- FlucytosineAnnals of Internal Medicine, 1977
- Inhibition of Potentially Pathogenic Yeastlike Fungi by Clotrimazole in Combination with 5-Fluorocytosine or Amphotericin BAntimicrobial Agents and Chemotherapy, 1976
- In vitro studies with 5-fluorocytosine.1969